PPI network shows AKT1, TNF, MAPK8, IL6, TP53, JUN, CASP3, CXCL8, VEGFA, PTGS2, especially AKT1, play a major effect on SQP anti-NAFLD. This evidence concerns the gene MAPK8 and metabolic dysfunction-associated steatotic liver disease.